Novartis reports topline outcomes from trial of Pluvicto for prostate cancer
Novartis has reported topline outcomes from the Phase III PSMAddition trial's pre-specified interim analysis, where Pluvicto (lutetium (177Lu) vipivotide tetraxetan), plus standard of care (SoC), has demonstrated a benefit in treating prostate-specific membrane antigen (PSMA)-positive metastatic hormone-sensitive prostate cancer (mHSPC).
The open-label trial met its primary endpoint, with the combo showing radiographic progression-free survival (rPFS) benefits with a positive trend in overall survival (OS) in this subject population.
The SoC in the PSMAddition trial includes a combo of androgen receptor pathway inhibitor (ARPI) therapy and androgen deprivation therapy (ADT).
This is the third positive read-out for this intravenous radioligand therapy (RLT), Pluvicto, in a Phase III trial, after the VISION and PSMAfore trials.
According to the company, findings from PSMAddition for mHSPC treatment show potential for treatment in an earlier setting with the RLT.
PSMAddition is a prospective, randomised trial that assesses the safety and efficacy of Pluvicto plus SoC versus SoC alone.
Subjects in the SoC arm are permitted to cross over to receive the RLT upon radiographic progression, as confirmed by a blinded independent review committee (BIRC).
Novartis noted that detailed data from the PSMAddition trial will be presented at a future medical meeting and submitted for regulatory review later this year.
The US Food and Drug Administration (FDA) recently approved the RLT for earlier use in mCRPC, based on outcomes from the PSMAfore trial.
Novartis Development president and chief medical officer Shreeram Aradhye said: 'The progression from metastatic hormone-sensitive prostate cancer to castration-resistant disease remains a formidable challenge that can profoundly impact the survival of patients.
'Following the recent FDA approval based on the PSMAfore trial in metastatic castration-resistant prostate cancer, these data suggest using it in an earlier disease setting could advance care and address a significant unmet need for hormone-sensitive prostate cancer patients."
This March, Novartis reported positive efficacy and safety outcomes from the Phase III clinical programme for OAV101 IT (onasemnogene abeparvovec), an investigational intrathecal therapy intended for spinal muscular atrophy (SMA) in subjects aged two to less than 18 years.
"Novartis reports topline outcomes from trial of Pluvicto for prostate cancer " was originally created and published by Clinical Trials Arena, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Food recall: Brown eggs sold at grocery stores across California have salmonella risk
A California company is recalling 1.7 million cartons of brown eggs — sold at stores including Walmart in nine states including California — because the eggs may be contaminated with salmonella bacteria. August Egg Company of Hilmar is recalling 1,700,000 dozen brown cage-free and brown certified organic eggs for potential salmonella risk. The eggs were distributed over the last four months, some with sell by dates as late as June 19, according to the recall notice from the Food and Drug Administration. The eggs are linked to an ongoing Salmonella Enteritidis outbreak in seven states, in which 79 people have been sickened and at least 21 hospitalized, but no deaths have been reported, according to the Centers for Disease Control and Prevention. Most of the people sickened (63) live in California, according to the CDC. Nevada and Washington reported four illnesses each, with additional cases in Arizona (3), New Jersey (2), Nebraska (2), Kentucky (1). Ill people in Kentucky, New Jersey, and Washington reported traveling to California and Nevada before they got sick. Most of those sickened (90%) reported eating eggs, the CDC said. Some samples taken by the FDA during an inspection at August Egg Company's processing facility tested positive for the strain of salmonella similar to those related to the persons sickened in the outbreak, the CDC said. August Egg Co. said its internal food safety team is conducting its own investigation to "identify what measures can be established to prevent this situation from recurring," the company said in a statement accompanying the recall. 'It is important to know that when our processing plant identified this concern, we immediately began diverting all eggs from the plant to an egg-breaking facility, which pasteurizes the eggs and kills any pathogens." USA TODAY Recall Database: Search vehicle, product and food recalls The recalled eggs were distributed beginning Feb. 3 across multiple retailers in nine states: Eggs with sell-by dates to June 4: Through May 15, eggs with those sell-by dates were distributed to Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raleys, Food 4 Less and Ralphs stores in California and Nevada. Eggs with sell-by dates to June 19: Through May 6, eggs with those sell-by dates were distributed to Walmart locations in California, Washington, Nevada, Arizona, Wyoming, New Mexico, Nebraska, Indiana and Illinois. August Egg Co. said consumers can identify the recalled eggs by the plant code on one side of the egg carton. They can return the eggs to the place of purchase for a refund. Consumers with questions can call the company at 1-800-710-2554, between 9 a.m. and 5 p.m. PT. Here's the products recalled with plant code and UPC. Salmonella causes about 1.35 million illnesses, 26,500 hospitalizations, and 420 deaths each year in the U.S., according to the CDC and FDA. Symptoms of salmonella infection – including diarrhea, fever and stomach cramps – typically arise six hours to six days after exposure and may last 4 to 7 days. Severe infections can also include aches, headaches, elevated fever, lethargy, rashes, and blood in the urine or stool. Salmonella poisoning, also known as salmonellosis, is a common gastrointestinal infection in California, with about 5,000 confirmed cases annually, according to the California Department of Public Health. The Centers for Disease Control estimates that around 3,000 people die from a foodborne illness, and of those about 420 people die from Salmonella infections. This article originally appeared on Palm Springs Desert Sun: Egg recall 2025: Salmonella risk for eggs sold at California stores
Business Upturn
2 hours ago
- Business Upturn
Ro Weight Loss Announces Official Website Update Featuring Natural Daily Program for Medically-Guided Weight Management
New York, June 07, 2025 (GLOBE NEWSWIRE) — Ro Weight Loss, a digital health service from Roman Health Ventures Inc., has updated its official website to provide new information about its medically-guided weight management program. Designed for adults across the United States, the offering connects eligible individuals with licensed healthcare providers through a secure telehealth platform. According to the official website ( Ro Weight Loss offers a structured approach to weight care, including FDA-approved treatment options when appropriate, along with personalized clinical support and lifestyle guidance. The service is designed to be accessible from home and does not require in-person clinic visits or restrictive dietary regimens. 'We created Ro Weight Loss to make effective, evidence-backed care more accessible,' said a Ro spokesperson. 'Our platform empowers people with a personalized plan, clinical oversight, and flexible support tailored to their health goals.' Ro states that the program prioritizes safety, transparency, and sustainable progress. After completing an online health assessment, users may be evaluated by board-certified providers to determine medical eligibility. When appropriate, providers may prescribe treatment as part of a comprehensive plan that includes coaching and follow-up. All care is delivered by licensed professionals, and medications are dispensed by U.S.-based pharmacies. The platform supports discreet access to care, ongoing communication with providers, and convenience for users managing their health goals remotely. The Ro Weight Loss program is currently available in all 50 states. Individuals interested in exploring eligibility or learning more about the service can visit the official website for additional information. About Ro Weight Loss Ro Weight Loss is a service provided by Roman Health Ventures Inc., a New York-based telehealth company offering evidence-based treatment across multiple areas of care, including weight management, mental health, dermatology, and more. Ro's digital platform empowers individuals to receive safe, personalized healthcare from the comfort of home. Product and Contact Information Brand: Ro Weight Loss Website: Email: [email protected] Mailing Address:Roman Health Ventures Inc.625 6th Ave, 4th Floor New York, NY 10011
Yahoo
2 hours ago
- Yahoo
Egg brands sold in Washington recalled, CDC warning of Salmonella outbreak
The U.S. Centers for Disease Control and Prevention (CDC) is warning of a Salmonella outbreak linked to several brands of eggs sold in nine states, including Washington. Seventy-nine people in seven states have contracted Salmonella linked to the same outbreak strain found in the eggs, the CDC says. The August Egg Company, based in Hilmar, California, has issued a recall of 1,700,000 dozen eggs sold at Walmart locations in Washington, according to the CDC. In a release, the CDC says twenty-one people have been hospitalized with Salmonella, and no deaths have been reported. The eggs were sold to retailers and restaurants in Arizona, California, Illinois, Indiana, Nebraska, New Mexico, Nevada, Washington, and Wyoming, the CDC says. The shell eggs were distributed from February 3 through May 6, with sell-by dates from March 4 to June 19, according to the Food and Drug Administration (FDA). In a release, the FDA says brands sold include: Clover Organic Large Brown Eggs O Organics Large Brown Eggs Marketside Organic Large Cage Free Brown Eggs Raley's Organic Large Cage Free Brown Eggs Simple Truth Medium & Large Brown Cage Free Eggs Sun Harvest Organic Cage Free Large Brown Eggs Sunnyside Large Brown Cage Free Eggs The eggs sold were distributed in fiber or plastic cartons with the plant code number P-6562 or CA5330. The CDC advises what you should do if you have a carton of recalled eggs in your home or business: What You Should Do: Do not eat any recalled eggs. Throw them away or return them to where you bought them. Wash items and surfaces that may have touched the recalled eggs using hot soapy water or a dishwasher. Call your healthcare provider if you have any severe Salmonella symptoms. What Businesses Should Do: Do not sell or serve recalled eggs. Wash and sanitize items and surfaces that may have come in contact with recalled eggs. About Salmonella: Most people infected with Salmonella develop diarrhea, fever, and stomach cramps 6 hours to 6 days after being exposed to the bacteria. The illness usually lasts 4 to 7 days, and most people recover without treatment. In some people, the illness may be so severe that the patient is hospitalized. Children younger than 5, adults 65 and older, and people with weakened immune systems are more likely to have severe illness. For more information, visit
